Drug search by name

Egrifta and Fluid retention

Result of checking the interaction of drug Egrifta and disease Fluid retention for safety when used together.

Check result:

Egrifta <> Fluid retention

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of tesamorelin may cause fluid retention related to the induction of growth hormone secretion. This manifests as increased tissue turgor and musculoskeletal discomfort resulting in adverse reactions (e.g. edema, arthralgia, and carpal tunnel syndrome) which are either transient or resolve with discontinuation of treatment. Care should be exercised when using tesamorelin in patients at risks for fluid retention.

Egrifta

Generic Name: tesamorelin

Brand Name: Egrifta

Synonyms: n.a.

What is Egrifta?